Acute otitis media, streptococcal tonsillitis, sinusitis, bronchitis, pneumonia with no signs of severity Infection due to Helicobacter pylori (in combination with omeprazole and clarithromycin), leptospirosis, uncomplicated cutaneous anthrax
Uncomplicated typhoid fever if the strain is susceptible (recent drug susceptibility test)
Completion treatment following therapy with parenteral penicillins or cephalosporins
Forms and strengths
250 mg and 500 mg tablets or capsules
250 mg dispersible scored tablet, for paediatric use 125 mg/5 ml powder for oral suspension:
to be reconstituted with filtered water
to be administered using a measuring device (oral syringe, measuring spoon, or cup with graduations)
Dosage
Usual dosage (e.g. leptospirosis, tonsillitis, infection due to H. pylori)